ArticleCommunications biology2026
Polo-like kinase Cdc5 orchestrates Cdk1 regulation via Swe1 and Mih1 during meiotic prophase I exit.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meiotic recombination defects activate a checkpoint that delays meiotic prophase I exit in budding yeast by inhibiting Ndt80-dependent expression of the cyclin CLB1 and the polo-like kinase CDC5. Additionally, Swe1-mediated inhibitory phosphorylation of Cdk1/Cdc28 on tyrosine 19 reinforces this arrest. Following checkpoint release, meiosis I entry depends on removal of inhibitory phosphorylation controlled by the opposing activities of Swe1 and the Mih1 phosphatase. Here, we define how this regulatory network is rewired at the prophase I-meiosis I transition. We show that Swe1 is required for checkpoint maintenance but not activation. We further demonstrate that Cdc5 promotes Cdk1 activation by inducing Swe1 degradation and facilitating Mih1 nuclear translocation. Unlike in mitosis, Swe1 degradation by Cdc5 does not require CDK priming and can occur upon artificial colocalization. These findings uncover an additional role for Cdc5 in promoting meiotic cell cycle progression, highlighting how conserved cell cycle regulators are adapted to drive meiosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.